Guaifenesin 62207-0570
Product NDC
62207-0570- Manufacturer
- Granules India Ltd
- Dosage Form
- Tablet, Extended Release
- Route
- Oral
- Product Type
- Human Otc Drug
- Marketing Start
- February 1, 2021
- Listing Expires
- December 31, 2026
- Application
- ANDA213420
Active Ingredients
| Ingredient | Strength |
|---|---|
| Guaifenesin | 600 mg/1 |
Drug Class
Expectorant [EPC]Decreased Respiratory Secretion Viscosity [PE]Expectorant [EPC]
Packaging Options(3)
20000 TABLET, EXTENDED RELEASE in 1 BAG (62207-570-30)
5400 TABLET, EXTENDED RELEASE in 1 BAG (62207-570-31)
4000 TABLET, EXTENDED RELEASE in 1 BAG (62207-570-92)